4
Changes in Ownership
Mirum Pharmaceuticals, Inc. Filed Acc 0001209191-23-049511
Director sold 14,608 shares at $32.00 ($467,456)
- Director acquired 14,608 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
GREY MICHAEL G · Director
Table I: Non-derivative
4 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2023-09-13 | Exercise or conversion : show line 1 in the form | +392 | $2.94 | $1,151 | 392 | D |
| 2023-09-13 | Sale : show line 2 in the form | −392 | $32.00 | $12,544 | 0 | D |
| 2023-09-14 | Exercise or conversion : show line 3 in the form | +14,216 | $2.94 | $41,738 | 14,216 | D |
| 2023-09-14 | Sale : show line 4 in the form | −14,216 | $32.00 | $454,912 | 0 | D |
| Open-market sales · 14,608 sh · avg $32.00 · $467,456 | ||||||
Table II: Derivative
2 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2023-09-13 | Exercise or conversion : show line 5 in the form Stock Option (right to buy) | −392 | 345,392 | D |
| 2023-09-14 | Exercise or conversion : show line 6 in the form Stock Option (right to buy) | −14,216 | 331,176 | D |
Loading xslF345X05/doc4.xml…